Rituximab (Mathera (500 mg)) is a monoclol antibody, prescribed for certain types of cancer such as lymphomas, leukemia, transplant rejection and some autoimmune disorders.It decreases the number of certain types of white blood cells (B cells) in the body.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Mathera (500 mg) - Roche Pharmaceuticals
Mathera (500 mg) Infusion
Generic : Rituximab
₹
76000
500mg/50ml/1vial
1vial
Substitute/Alternative Medication to Mathera (500 mg)
When is Mathera (500 mg) prescribed?
It is prescribed for -